Future mCRC Directions: Enhancing Anti-EGFR Therapy With Novel Combination Strategies

Host: Scott Kopetz, MD, PhD


Host: Cathy Eng, MD, FACP

This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.